AU1275195A - Human interferon expression vectors for treating aids - Google Patents

Human interferon expression vectors for treating aids

Info

Publication number
AU1275195A
AU1275195A AU12751/95A AU1275195A AU1275195A AU 1275195 A AU1275195 A AU 1275195A AU 12751/95 A AU12751/95 A AU 12751/95A AU 1275195 A AU1275195 A AU 1275195A AU 1275195 A AU1275195 A AU 1275195A
Authority
AU
Australia
Prior art keywords
expression vectors
human interferon
treating aids
interferon expression
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12751/95A
Other languages
English (en)
Inventor
Philippe Leissner
Majid Mehtali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Publication of AU1275195A publication Critical patent/AU1275195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU12751/95A 1993-12-13 1994-12-13 Human interferon expression vectors for treating aids Abandoned AU1275195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9314915 1993-12-13
FR9314915A FR2713657B1 (fr) 1993-12-13 1993-12-13 Nouveaux vecteurs pour le traitement du sida.
PCT/FR1994/001458 WO1995016784A1 (fr) 1993-12-13 1994-12-13 Vecteurs exprimant un interferon humain pour le traitement du sida

Publications (1)

Publication Number Publication Date
AU1275195A true AU1275195A (en) 1995-07-03

Family

ID=9453844

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12751/95A Abandoned AU1275195A (en) 1993-12-13 1994-12-13 Human interferon expression vectors for treating aids

Country Status (7)

Country Link
EP (1) EP0682712A1 (fr)
JP (1) JPH08506970A (fr)
AU (1) AU1275195A (fr)
CA (1) CA2155568A1 (fr)
FR (1) FR2713657B1 (fr)
SG (1) SG49230A1 (fr)
WO (1) WO1995016784A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004799A (en) * 1996-03-05 1999-12-21 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral DNA vaccines
EP0951544A2 (fr) * 1996-07-03 1999-10-27 Chiron Corporation Procedes d'administration de porteurs fournissant des genes recombinants pour le traitement d'une maladie chez l'homme
US6696423B1 (en) 1997-08-29 2004-02-24 Biogen, Inc. Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
KR100776475B1 (ko) 2000-02-02 2007-11-16 안제스에무지 가부시키가이샤 유전자 전달을 위한 바이러스 엔벨로프 벡터
US11325948B2 (en) 2016-03-19 2022-05-10 Exuma Biotech Corp. Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
SG10202104509PA (en) * 2016-03-19 2021-06-29 Exuma Biotech Corp Methods and compositions for transducing lymphocytes and regulated expansion thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0266940B1 (fr) * 1986-10-22 1992-12-16 Schering Corporation Utilisation de l'alpha-interferon humain pour l'obtention d'un medicament pour le traitement du virus du SIDA
WO1990011359A1 (fr) * 1989-03-20 1990-10-04 Whitehead Institute For Biomedical Research Procede intracellulaire d'inhibition de l'hiv dans des cellules de mammiferes
DE69230506T2 (de) * 1991-10-25 2000-06-21 Sidney Kimmel Cancer Center Sa Lymphokine gentherapie bei krebs in kombination mit tumorantigenen

Also Published As

Publication number Publication date
CA2155568A1 (fr) 1995-06-22
EP0682712A1 (fr) 1995-11-22
WO1995016784A1 (fr) 1995-06-22
FR2713657B1 (fr) 1996-03-01
FR2713657A1 (fr) 1995-06-16
SG49230A1 (en) 1998-05-18
JPH08506970A (ja) 1996-07-30

Similar Documents

Publication Publication Date Title
AU659788B2 (en) Human body moving apparatus
AU685356B2 (en) Interferon solution
AU4944093A (en) Osteosynthesis aid
AU7353494A (en) Episomal expression vector for human gene therapy
AU5975694A (en) Electrotherapeutic apparatus
AU699706C (en) Improved vectors for gene therapy
AU1966992A (en) Skin treatment system
AU6923294A (en) Personal object carrying medical details
AU4514193A (en) Bone formation-inducing protein
AU3351693A (en) Anatomical air-mattress
AUPM761094A0 (en) Treatment of hides
AU1081295A (en) Biomedical electrode
AU5758594A (en) Treatment of viral infections
AU5340594A (en) Skin treatment
AU1275195A (en) Human interferon expression vectors for treating aids
AU5737494A (en) Human thrombospondin-4
AU6575894A (en) Body massager
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
AU8879691A (en) Treatment of dispersions
AU6551894A (en) Biomedical electrode
AU3641993A (en) Treatment chamber
AU6574894A (en) Herbicidal treatment
AU5419894A (en) Dental treatment aid
GB9305316D0 (en) Skin emollinets
AU4466493A (en) Neutrophil stimulating peptides